Cereno Scientific AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-99.53	-48.11	-27.65	-16.25	-16.02	Upgrade
Depreciation & Amortization	0.29	0.01	0.01	0.01	0.01	Upgrade
Other Operating Activities	1.43	2.48	0.36	0.91	1.1	Upgrade
Change in Accounts Receivable	-3.86	0.05	0.02	-0.08	-0.19	Upgrade
Change in Other Net Operating Assets	-1.75	8.64	8.65	2.28	-1.04	Upgrade
Operating Cash Flow	-103.42	-36.92	-18.62	-13.14	-16.14	Upgrade
Capital Expenditures	-3.87	-	-	-	-0.01	Upgrade
Sale (Purchase) of Intangibles	-80.9	-49.28	-57.54	-44.81	-8.22	Upgrade
Other Investing Activities	-	-	-	-	-0.01	Upgrade
Investing Cash Flow	-84.77	-49.28	-57.54	-44.81	-8.24	Upgrade
Long-Term Debt Issued	155	45	-	-	10	Upgrade
Total Debt Issued	155	45	-	-	10	Upgrade
Long-Term Debt Repaid	-	-	-5	-5	-	Upgrade
Net Debt Issued (Repaid)	155	45	-5	-5	10	Upgrade
Issuance of Common Stock	76.68	77.01	61.28	95.31	59.22	Upgrade
Other Financing Activities	-3.08	-15.69	-2.72	-8.74	-4.93	Upgrade
Financing Cash Flow	228.61	106.31	53.56	81.57	64.29	Upgrade
Miscellaneous Cash Flow Adjustments	-0	-0	-	-	-	Upgrade
Net Cash Flow	40.41	20.12	-22.59	23.63	39.9	Upgrade
Free Cash Flow	-107.29	-36.92	-18.62	-13.14	-16.15	Upgrade
Free Cash Flow Margin	-132.62%	-74.91%	-32.35%	-29.32%	-196.40%	Upgrade
Free Cash Flow Per Share	-0.38	-0.16	-0.14	-0.13	-0.22	Upgrade
Cash Interest Paid	-	-	0.63	0.33	-	Upgrade
Levered Free Cash Flow	-143.79	-70.75	-66.14	-52.39	-	Upgrade
Unlevered Free Cash Flow	-127.49	-67.44	-65.86	-51.61	-	Upgrade
Change in Net Working Capital	-4.4	-9.47	-8.29	-2.42	-	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.